What does CUSIP 31572Q881 represent in this 13F holders report?

CUSIP 31572Q881 is the security identifier for KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value used to aggregate holder disclosures.

How many institutions held KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value in Q1 2026?

31 institutional investors reported KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value for Q1 2026. Use the holders table for investor-level position and value details.

KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB)

CUSIP: 31572Q881

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, $0.01 par value
Total 13F shares: 1,034,728
Total 13F value: $7,013,757
Share change: -116,562
Put/Call ratio: 0%
SEC-reported price per share: $6.78
Number of holders: 31
Value change: -$1,066,549
Number of buys: 9
Number of sells: 15
Shares outstanding: 4,048,583

Security key

31572Q881

Report period

Q1 2026

Institutions

Top holders

KYNB full security history Ownership snapshot Full 13F holder table KYNTRA BIO, INC. SEC filings KYNTRA BIO, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2025

13F 13D/G Lead comparable stake: 9.9% 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 5

ARMISTICE CAPITAL, LLC 9.9%

PRIMECAP MANAGEMENT CO/CA/ 4.6%

VANGUARD GROUP INC 4.4%

ACADIAN ASSET MANAGEMENT LLC 2.6%

BlackRock, Inc. 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F 13D/G Company 13F 13D/G	9.9% from 13D/G	$3,512,000 400,000 shares	—	31 Dec 2025
PRIMECAP MANAGEMENT CO/CA/	13D/G 13D/G	4.6%	$1,523,323 4,616,130 shares	$0	31 Dec 2024
VANGUARD GROUP INC	13F 13D/G Company · The Vanguard Group 13F 13D/G	4.4% from 13D/G	$1,597,723 181,973 shares	—	31 Dec 2025
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	2.6%	$925,000 105,585 shares	—	31 Dec 2025
BlackRock, Inc.	13F Company 13F	2.1%	$743,579 84,690 shares	—	31 Dec 2025
TWO SIGMA INVESTMENTS, LP	13F Company 13F	1.5%	$537,433 61,211 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,034,728

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %